AUGMENTIN INTRAVENOUS 600MG

Šalis: Malaizija

kalba: anglų

Šaltinis: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Veiklioji medžiaga:

AMOXYCILLIN SODIUM; CLAVULANIC ACID

Prieinama:

GLAXOSMITHKLINE PHARMACEUTICAL SDN. BHD.

INN (Tarptautinis Pavadinimas):

AMOXYCILLIN SODIUM; CLAVULANIC ACID

Pagaminta:

SMITHKLINE BEECHAM PHARMACEUTICALS

Prekės savybės

CONFIDENTIAL

AUGMENTIN
TM INTRAVENOUS
AMOXICILLIN SODIUM - POTASSIUM CLAVULANATE
QUALITATIVE AND QUANTITATIVE COMPOSITION
_AUGMENTIN_ 600 mg intravenous: 500 mg amoxicillin (as amoxicillin
sodium) and
100 mg clavulanic acid (as potassium clavulanate) for reconstitution
as an intravenous
injection or infusion.
_AUGMENTIN_ 1.2 g intravenous: 1 g amoxicillin (as amoxicillin sodium)
and 200 mg
clavulanic acid (as potassium clavulanate)_ _for reconstitution as an
intravenous
injection or infusion.
PHARMACEUTICAL FORM
Sterile powder for injection.
CLINICAL PARTICULARS
INDICATIONS
_AUGMENTIN _should be used in accordance with local official
antibiotic-prescribing
guidelines and local susceptibility data.
_AUGMENTIN_ is indicated for short-term treatment of bacterial
infections at the following
sites:
_Upper respiratory tract infections (including ENT) _e.g. recurrent
tonsillitis, sinusitis,
otitis media.
_Lower respiratory tract infections _e.g. acute exacerbation of
chronic bronchitis, lobar and
bronchopneumonia.
_Genito-urinary tract infections _e.g. cystitis, urethritis,
pyelonephritis.
_Skin and soft tissue infections,_ e.g. boils, abscesses, cellulitis,
wound infections._ _
_Bone and joint infections _e.g. osteomyelitis.
_Other infections _e.g. intra-abdominal sepsis.
_AUGMENTIN_ intravenous is also indicated for prophylaxis against
infection which may
be associated with major surgical procedures such as gastrointestinal,
pelvic, head and
neck, cardiac, renal, joint replacement and biliary tract.
Susceptibility to _AUGMENTIN_ will vary with geography and time (see
_Pharmacological _
_Properties, Pharmacodynamics_ for further information). Local
susceptibility data should
be consulted where available, and microbiological sampling and
susceptibility testing
performed where necessary.
CONFIDENTIAL

Infections caused by amoxicillin-susceptible organisms are amenable to
_AUGMENTIN_
treatment due to its amoxicillin content. Mixed infections caused by
amoxicillin -
susceptible organisms in conjunc